NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition
Hui Tong,1,* Xiaohui Liu,2,* Tao Li,1 Weihua Qiu,1 Chenghong Peng,1 Baiyong Shen,1 Zhecheng Zhu1 1Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China; 2CNRS-LIA124, Sino-French Research Center for Lif...
Main Authors: | Tong H, Liu X, Li T, Qiu W, Peng C, Shen B, Zhu Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/nr1d2-accelerates-hepatocellular-carcinoma-progression-by-driving-the--peer-reviewed-article-OTT |
Similar Items
-
INTS8 accelerates the epithelial-to-mesenchymal transition in hepatocellular carcinoma by upregulating the TGF-β signaling pathway
by: Tong H, et al.
Published: (2019-02-01) -
HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
by: Hong-bo Huan, et al.
Published: (2017-06-01) -
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes
by: Chen Xiong, et al.
Published: (2020-01-01) -
NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells
by: Baili Xia, et al.
Published: (2020-07-01) -
Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
by: Rongzhong Xu, et al.
Published: (2021-06-01)